<DOC>
	<DOCNO>NCT02452034</DOCNO>
	<brief_summary>This study aim evaluate pharmacokinetics posaconazole ( POS ) administer intravenously ( IV ) orally immunocompromised pediatric participant .</brief_summary>
	<brief_title>Safety Pharmacokinetics Intravenous Oral Posaconazole Immunocompromised Children ( MK-5592-097 )</brief_title>
	<detailed_description />
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Posaconazole</mesh_term>
	<criteria>Have document anticipate neutropenia expect last least 7 day , follow treatment least one follow clinical situation : acute leukemia , myelodysplasia , severe aplastic anemia , recipient Autologous hematopoietic stem cell transplant ( HSCT ) , high risk neuroblastoma , advanced stage nonHodgkin 's lymphoma , hemophagocytic lymphohistiocytosis Have central line place prior IV study therapy Participants reproductive potential agree remain abstinent , use medically accept method birth control Has prove probable invasive fungal infection Has receive formulation POS within prior 10 day Is receive prohibit drug Has laboratory result outside normal limit screen , follow : ) Moderate severe liver dysfunction , define : Aspartate aminotransferase ( AST ) &gt; 5 time upper limit normal ( ULN ) , OR Alanine aminotransferase ( ALT ) &gt; 5 time ULN , OR Serum total bilirubin &gt; 2.5 time ULN , OR AST ALT &gt; 3 time ULN total bilirubin &gt; 2 time ULN ; b ) Calculated creatinine clearance &lt; 30 mL/min . Has QTc ( QT interval correct rate ) prolongation define : ) Symptomatic QTc prolongation &gt; 450 msec ( male ) &gt; 470 msec ( female ) OR b ) Any QTc prolongation &gt; 500 msec Is pregnant , intend become pregnant study , breastfeeding Has history anaphylaxis attribute azole class antifungal agent Is expect receive minimum 10 day POS IV solution Has participate Phase 1 Investigational New Drug ( IND ) study within prior 30 day expect within follow 60 day Is immediate family member ( e.g. , spouse , parent/legal guardian , sibling child ) investigational site sponsor staff directly involve trial .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>